Abstract
SummaryMacrophages exposed to chymotrypsin, trypsin, or pronase failed to ingest aggregated albumin or ferritin in vitro. Treatment with neuraminidase, RNase, albumin, or DFP-chymotrypsin had no apparent effect on macrophage pinocytosis. When cells treated with active chymotrypsin were subsequently maintained in culture, they recovered their ability to ingest protein. This recovery was inhibited by partial inhibition of protein synthesis with cycloheximide. Since chymotrypsin itself is not ingested, the results are interpreted to indicate the removal or inactivation of a surface factor required for pinocytosis that is generated by the cell.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
